Sbc Medical Group Holdings INC

SBC Medical Group Holdings Incorporated is addressing Nasdaq's independent director and audit committee requirements following a board member's departure, with a cure period until July 2027.

SBC Medical Group Holdings Incorporated announces director departure and board size reduction, with plans to appoint a new independent director.

SBC Medical Group Holdings reported a 9% year-over-year revenue decrease to $43 million for Q1 2026, attributed to a franchise fee structure revision, while net income fell 47% to $11 million.

SBC Medical Group Holdings Incorporated announced its fourth quarter and full year 2025 financial results, showing significant net income growth despite revenue declines due to strategic restructuring.

SBC Medical Group Holdings Incorporated announced a strategic minority equity investment in U.S. MedSpa chain OrangeTwist, marking its formal entry into the U.S. medical aesthetics market.

SBC Medical Group Holdings Incorporated announced an updated capital strategy, including a $20 million share repurchase program and the effectiveness of a $50 million Form S-3 shelf registration statement.

SBC Medical Group Holdings reports a 9% decrease in Q1 2026 revenue, primarily driven by changes in its franchising fee structure and a decline in procurement orders.

SBC Medical Group Holdings Incorporated reported a significant increase in net income for Q3 2025 despite a decline in overall revenues, driven by non-operating gains and reduced operating expenses.

SBC Medical Group Holdings Incorporated reported a significant decline in net income and negative operating cash flow for Q2 2025, despite growth in procurement and rental services revenue.

SBC Medical Group Holdings Incorporated reports a decrease in revenue but an increase in net income for the quarter ended March 31, 2025, compared to the same period in 2024.

SBC Medical Group Holdings saw a revenue increase in Q3 2024, but net income decreased compared to the same period last year due to increased operating expenses and other factors.

Pono Capital Two, Inc. reported a net loss for the second quarter of 2024, while continuing efforts to finalize its business combination with SBC Medical Group Holdings.

SBC Medical Group Holdings files an amendment to its 2025 Annual Report to provide required Part III disclosures and updated certifications.

SBC Medical Group Holdings Incorporated reported a 9.33% increase in net income for 2025, alongside strategic acquisitions and ongoing international expansion, despite a 15.48% decrease in total revenues.

SBC Medical Group Holdings files an amendment to its 2024 annual report, primarily to restate information regarding related person transactions and director independence, and to include updated certifications and executive employment agreements.

SBC Medical Group Holdings files an amendment to its 2024 annual report to include previously omitted information on directors, executive compensation, and corporate governance, while also updating details on a new executive employment agreement.

SBC Medical Group Holdings Incorporated provides a detailed overview of its capital stock, warrant terms, and anti-takeover provisions in its latest 10-K filing.

Pono Capital Two, Inc.'s 10-K filing outlines its share structure, governance, and ongoing efforts to complete a business combination, including amendments to its merger agreement and extension of deadlines.

Chairman and CEO Yoshiyuki Aikawa sold 465,000 shares of SBC Medical Group Holdings Inc following an underwritten public offering.

Chairman and CEO Yoshiyuki Aikawa sold 3.1 million shares of SBC Medical Group Holdings Inc. as part of an underwritten public offering.

Director Mike Sayama receives 15,000 shares of SBC Medical Group Holdings Inc. common stock from Mehana Capital LLC.

ZUU Co. Ltd. and related entities report transactions involving SBC Medical Group Holdings Inc. common stock and warrants, including a transfer of shares and a sale of shares at a weighted average price.

Yoshiyuki Aikawa, Director, Chairman, and CEO of SBC Medical Group Holdings Inc, reports the transfer of 1,503,473 shares of common stock on September 17, 2024, pursuant to a Non-Redemption Agreement.

ZUU Co. Ltd. and related entities report acquiring additional Class A Common Stock of Pono Capital Two, Inc. (PTWO) through open market purchases.

SBC Medical Group Holdings Incorporated announces its 2026 Annual Meeting of Stockholders, to be held virtually on July 9, 2026, featuring director elections and charter amendments.

SBC Medical Group Holdings Incorporated announced its 2025 annual meeting of stockholders, to be held virtually on June 13, 2025, where key proposals include the election of directors, ratification of its independent auditor, and a significant amendment to declassify its board of directors.

Pono Capital Two, Inc. updates its non-redemption agreement to bolster its proposed business combination with SBC Medical Group Holdings Incorporated.

Pono Capital Two, Inc. is seeking stockholder approval for its proposed merger with SBC Medical Group Holdings Incorporated, outlined in a definitive proxy statement.

Pono Capital Two amends its non-redemption agreement to extend the deadline for its business combination with SBC Medical Group to September 16, 2024.

Pono Capital Two, Inc. has amended its merger agreement with SBC Medical Group Holdings Incorporated to extend the outside date for completing the business combination to September 30, 2024.

SBC Medical Group is registering the potential issuance of shares upon warrant exercise and the resale of existing shares and warrants by selling securityholders following its recent merger.

Yoshiyuki Aikawa, CEO of SBC Medical Group Holdings, completed a secondary offering of 3.1 million shares while retaining a dominant 82.2% stake.

Aikawa Equity Management Co., Ltd. has reported a 5.2% beneficial ownership stake in SBC Medical Group Holdings Inc., acquiring 5,284,500 shares of common stock.